Saint-Herblain (France), December 4, 2024 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces the publication of an article on the global health and economic ...
We are proud to announce the groundbreaking new innovations selected in Grand Challenges Senegal’s first two funding calls. The selected projects address epidemic intelligence, surveillance, and ...